GLUE vs ILMN · rev $13.2M vs rev $2.25B
Monte Rosa Therapeutics Inc (GLUE) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Latest reported GLUE revenue for 2026-06-30 was $13.2M. Net income was -$87.9M. GLUE currently screens at market cap $1.56B.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
GLUE currently screens at market cap $1.56B. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the GLUE and ILMN stock pages for the full models.
Not investment advice.